The therapeutic potential of targeting CD40-TRAF6 pathway in cardiovascular Diseases.
暂无分享，去创建一个
M. Brans | G. Pasterkamp | E. Lutgens | S. D. de Jager | T. Seijkens | C. van Tiel | L. Bosch | J. de Haan
[1] F. Ginhoux,et al. Inhibiting Inflammation with Myeloid Cell‐Specific Nanobiologics Promotes Organ Transplant Acceptance , 2018, Immunity.
[2] Bin Zhang,et al. Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates , 2018, Nature Biomedical Engineering.
[3] G. Vriend,et al. Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis , 2018, Journal of the American College of Cardiology.